Recruiting Temporal Lobe Epilepsy Studies in Tucson
ABTECT - Maintenance
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy....
About Temporal Lobe Epilepsy Clinical Trials in Tucson
Temporal lobe epilepsy is the most common form of focal epilepsy, with seizures originating in the temporal lobe of the brain. It can cause unusual sensations, memory problems, and altered consciousness. Treatment includes antiseizure medications and surgery for drug-resistant cases.
There are currently 2 temporal lobe epilepsy clinical trials recruiting participants in Tucson, ARIZONA. These studies are seeking a combined 1,440 participants. Research is being sponsored by Abivax S.A., Biohaven Therapeutics Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Temporal Lobe Epilepsy Clinical Trials in Tucson — FAQ
Are there temporal lobe epilepsy clinical trials in Tucson?
Yes, there are 2 temporal lobe epilepsy clinical trials currently recruiting in Tucson, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tucson?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.
Are clinical trials in Tucson free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.
What temporal lobe epilepsy treatments are being tested?
The 2 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for temporal lobe epilepsy.
Data updated March 2, 2026 from ClinicalTrials.gov